This Solicitation opportunity from Government of Canada was posted on December 22, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Potassium Iodide tablets
Closed
W6369-26-A029CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of National DefenceView Agency
NAICS
N/A
Place of Performance
*Canada *Petawawa *Ontario (except NCR), CANSet-Aside
NONE
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of National Defence
Contacts1 person available
OfficeN/A
Office AddressN/A
Contacts
Full Description
Show more
The Strategic Medical Countermeasures Program (SMCP), on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp) has a requirement for Potassium Iodide tablets for use as a thyroid blocking agent for use in nuclear emergencies which involve the release of radioiodine.
The Contract Period will be from contract award to 31 March 2030.
The Crown retains the rights to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.
Applicable trade agreements:
Canadian Free Trade Agreement
Canadian-Colombia Free Trade Agreement
Canada-Honduras Free Trade Agreement
Canada-Panama Free Trade Agreement
Canada-Korea Free Trade Agreement
Canada-Peru Free Trade Agreement
Canada-Chili Free Trade Agreement